Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.92
+4.23 (90.19%)
At close: Jun 6, 2025, 4:00 PM
8.90
-0.02 (-0.22%)
After-hours: Jun 6, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Vonoprazan
55.25M
Log In
Vonoprazan Growth
8001.47%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
United States
55.25M
Log In
United States Growth
8001.47%
Log In